Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Prabakaran A, Mukta Agrawal, Mithun Rajendra Dethe, Hafiz Ahmed, Awesh Yadav, Umesh Gupta & Amit Alexander. (2022) Nose-to-brain drug delivery for the treatment of Alzheimer’s disease: current advancements and challenges. Expert Opinion on Drug Delivery 19:1, pages 87-102.
Read now
Read now
Shourya Tripathi, Ujala Gupta, Rewati Raman Ujjwal & Awesh K. Yadav. (2021) Nano-lipidic formulation and therapeutic strategies for Alzheimer’s disease via intranasal route. Journal of Microencapsulation 38:7-8, pages 572-593.
Read now
Read now
Liang Kong, Xue-tao Li, Ying-nan Ni, Hong-he Xiao, Ying-jia Yao, Yuan-yuan Wang, Rui-jun Ju, Hong-yan Li, Jing-jing Liu, Min Fu, Yu-tong Wu, Jing-xian Yang & Lan Cheng. (2020) Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer’s Disease-Related Pathology in APP/PS-1 Mice. International Journal of Nanomedicine 15, pages 2841-2858.
Read now
Read now
Abdulrahman K Al Asmari, Zabih Ullah, Mohammad Tariq & Amal Fatani. (2016) Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil. Drug Design, Development and Therapy 10, pages 205-215.
Read now
Read now
Articles from other publishers (34)
Chao Gao, Yan Liu, Ting-Lin Zhang, Yi Luo, Jie Gao, Jian-Jian Chu, Bao-Feng Gong, Xiao-Han Chen, Tong Yin, Jian Zhang & You Yin. (2023) Biomembrane-Derived Nanoparticles in Alzheimer’s Disease Therapy: A Comprehensive Review of Synthetic Lipid Nanoparticles and Natural Cell-Derived Vesicles. International Journal of Nanomedicine Volume 18, pages 7441-7468.
Crossref
Crossref
Lucia Zakharova, Gulnara Gaynanova, Elmira Vasilieva, Leysan Vasileva, Rais Pavlov, Ruslan Kashapov, Konstantin Petrov & Oleg Sinyashin. (2023) Recent Nanoscale Carriers for Therapy of Alzheimer's Disease:
Current Strategies and Perspectives. Current Medicinal Chemistry 30:33, pages 3743-3774.
Crossref
Crossref
Dong-Dong Wu, Yasmine Ahmed Salah, Ebenezeri Erasto Ngowi, Yan-Xia Zhang, Saadullah Khattak, Nazeer Hussain Khan, Yan Wang, Tao Li, Zi-Hua Guo, Yan-Mei Wang & Xin-Ying Ji. (2023) Nanotechnology prospects in brain therapeutics concerning gene-targeting and nose-to-brain administration. iScience 26:8, pages 107321.
Crossref
Crossref
Paulo Faria, Catarina Pacheco, Rui Pedro Moura, Bruno Sarmento & Cláudia Martins. (2022) Multifunctional nanomedicine strategies to manage brain diseases. Drug Delivery and Translational Research 13:5, pages 1322-1342.
Crossref
Crossref
Melody D. Fulton & Wided Najahi-Missaoui. (2023) Liposomes in Cancer Therapy: How Did We Start and Where Are We Now. International Journal of Molecular Sciences 24:7, pages 6615.
Crossref
Crossref
Somrita Padma, Subhankar Dey, Monojit Banerjee, Biplob Kumar Modak & Suprabhat Mukherjee. 2023. Nanomaterials for Bioreactors and Bioprocessing Applications. Nanomaterials for Bioreactors and Bioprocessing Applications
365
401
.
Vivek P. Chavda, Gargi Jogi, Nirav Shah, Mansi N. Athalye, Nirav Bamaniya, Lalitkumar K Vora & Ana Cláudia Paiva-Santos. (2022) Advanced particulate carrier-mediated technologies for nasal drug delivery. Journal of Drug Delivery Science and Technology 74, pages 103569.
Crossref
Crossref
Ashish Dhiman, Mayank Handa, Munindra Ruwali, Dhirendra Pratap Singh, Prashant Kesharwani & Rahul Shukla. (2022) Recent trends of natural based therapeutics for mitochondria targeting in Alzheimer’s disease. Mitochondrion 64, pages 112-124.
Crossref
Crossref
Carely Hernandez & Surabhi Shukla. (2022) Liposome based drug delivery as a potential treatment option for Alzheimer’s disease. Neural Regeneration Research 17:6, pages 1190.
Crossref
Crossref
Syed Nasir Abbas Bukhari. (2022) Nanotherapeutics for Alzheimer's Disease with Preclinical Evaluation and
Clinical Trials: Challenges, Promises and Limitations. Current Drug Delivery 19:1, pages 17-31.
Crossref
Crossref
Gourav Paudwal, Nagma Banjare & Prem N. Gupta. 2022. Applications of Nanovesicular Drug Delivery. Applications of Nanovesicular Drug Delivery
81
101
.
Pallav Namdeo, Jinu Mathew & Ashish Garg. 2022. Nanomedical Drug Delivery for Neurodegenerative Diseases. Nanomedical Drug Delivery for Neurodegenerative Diseases
223
242
.
Claudia Riccardi, Filomena Napolitano, Daniela Montesarchio, Simone Sampaolo & Mariarosa Anna Beatrice Melone. (2021) Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases. Pharmaceutics 13:11, pages 1897.
Crossref
Crossref
Yuzhe Sun & Edward Davis. (2021) Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms. Nanomaterials 11:3, pages 746.
Crossref
Crossref
Pragya Prasanna & Arun Upadhyay. (2021) Flavonoid-Based Nanomedicines in Alzheimer’s Disease Therapeutics: Promises Made, a Long Way To Go. ACS Pharmacology & Translational Science 4:1, pages 74-95.
Crossref
Crossref
Prashant K. Deshmukh, Swapnil N. Jain, Pravin O. Patil & Chandrakantsing V. Pardeshi. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
209
223
.
Annu, Ali Sartaj, Nidhi Aggarwal, Zufika Qamar, Heena Tabassum, Jasjeet K. Narang, Sanjula Baboota & Javed Ali. 2021. Nanocarriers for the Delivery of Combination Drugs. Nanocarriers for the Delivery of Combination Drugs
47
83
.
Sara Silva, António J. Almeida & Nuno Vale. (2021) Acetylcholinesterase inhibitors and nanoparticles on Alzheimer’s disease: a review. Journal of Nanoparticle Research 23:1.
Crossref
Crossref
Hiba Natsheh & Elka Touitou. (2020) Phospholipid Vesicles for Dermal/Transdermal and Nasal Administration of Active Molecules: The Effect of Surfactants and Alcohols on the Fluidity of Their Lipid Bilayers and Penetration Enhancement Properties. Molecules 25:13, pages 2959.
Crossref
Crossref
Anmol Dogra, R.S. Narang & Jasjeet K. Narang. (2020) Recent Advances in Nanotherapeutic Interventions for the Treatment of Alzheimer’s Disease. Current Pharmaceutical Design 26:19, pages 2257-2279.
Crossref
Crossref
Bapi Gorain, Davinaa C. Rajeswary, Manisha Pandey, Prashant Kesharwani, Santosh A. Kumbhar & Hira Choudhury. (2020) Nose to Brain Delivery of Nanocarriers Towards Attenuation of Demented Condition. Current Pharmaceutical Design 26:19, pages 2233-2246.
Crossref
Crossref
Saba Naqvi, Archna Panghal & S. J. S. Flora. (2020) Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs. Frontiers in Neuroscience 14.
Crossref
Crossref
Shiv Bahadur, Nidhi Sachan, Ranjit K. Harwansh & Rohitas Deshmukh. (2020) Nanoparticlized System: Promising Approach for the Management of Alzheimer’s Disease through Intranasal Delivery. Current Pharmaceutical Design 26:12, pages 1331-1344.
Crossref
Crossref
Miguel Pinto, Sofia Benfeito, Carlos Fernandes & Fernanda Borges. 2020. Oxidative Stress and Dietary Antioxidants in Neurological Diseases. Oxidative Stress and Dietary Antioxidants in Neurological Diseases
125
141
.
Nishan K. Shah, Elisa A. Torrico Guzmán, Zimeng Wang & Samantha A. Meenach. 2020. Nanoparticles for Biomedical Applications. Nanoparticles for Biomedical Applications
67
87
.
Soon-Seok Hong, Kyung Taek Oh, Han-Gon Choi & Soo-Jeong Lim. (2019) Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives. Pharmaceutics 11:10, pages 540.
Crossref
Crossref
Zi-Ying Wang, Sravan Gopalkrishnashetty Sreenivasmurthy, Ju-Xian Song, Jing-Yi Liu & Min Li. (2019) Strategies for brain-targeting liposomal delivery of small hydrophobic molecules in the treatment of neurodegenerative diseases. Drug Discovery Today 24:2, pages 595-605.
Crossref
Crossref
Josef Jampílek, Katarína Kráľová, Petr Novák & Michal Novák. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases
65
138
.
Hiba Natsheh & Elka Touitou. (2018) Phospholipid Magnesome—a nasal vesicular carrier for delivery of drugs to brain. Drug Delivery and Translational Research 8:3, pages 806-819.
Crossref
Crossref
Jing-Wen Guo, Pei-Pei Guan, Wei-Yan Ding, Si-Ling Wang, Xue-Shi Huang, Zhan-You Wang & Pu Wang. (2017) Erythrocyte membrane-encapsulated celecoxib improves the cognitive decline of Alzheimer's disease by concurrently inducing neurogenesis and reducing apoptosis in APP/PS1 transgenic mice. Biomaterials 145, pages 106-127.
Crossref
Crossref
Asya Ozkizilcik, Parker Davidson, Hulusi Turgut, Hari S. Sharma, Aruna Sharma & Z. Ryan Tian. 2017. Drug and Gene Delivery to the Central Nervous System for Neuroprotection. Drug and Gene Delivery to the Central Nervous System for Neuroprotection
33
55
.
Gisele C. Vaz, Neeru M. Sharma, Hong Zheng, Matthew C. Zimmerman, Robson S. Santos, Frederic Frezard, Marco A.P. Fontes & Kaushik P. Patel. (2016) Liposome-entrapped GABA modulates the expression of nNOS in NG108-15 cells. Journal of Neuroscience Methods 273, pages 55-63.
Crossref
Crossref
D. Carradori, A. Gaudin, D. Brambilla & K. Andrieux. 2016. Nanotechnology and the Brain. Nanotechnology and the Brain
73
113
.
Rajshree L. Shinde, Gopal P. Bharkad & Padma V. Devarajan. (2015) Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid. European Journal of Pharmaceutics and Biopharmaceutics 96, pages 363-379.
Crossref
Crossref